comparemela.com
  1. Home
  2. Live Updates
  3. Arnold Lippa - Breaking News

Page 2 - Arnold Lippa News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ResolutionRx Secures $3 1M for OSA Drug Clinical Trial R&D

ResolutionRx secured $3.1 million in financing to support clinical trial R&D for a new formulation of dronabinol for the treatment of OSA.

United statesArnold lippaDevelopment tax incentiveAustralian researchDrug administrationCantheon capitalRadium capital

ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc , Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs

ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc , Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesGlen rockNew south walesArnold lippaJeff margolisRespirerx pharmaceuticals incMilwaukee research foundation incCompany contactPrimarymarkets pty ltdNational institutes of healthDavid fuller university of floridaCompany annual report on formAustralian securities exchangeRespirerx groupSecurities exchangeExchange commission

RespireRx Pharmaceuticals Inc s Australia cannabis subsidiary ResolutionRx Ltd inks LOI securing $3 1M investment from Cantheon Capital

RespireRx Pharmaceuticals Inc s Australia cannabis subsidiary ResolutionRx Ltd inks LOI securing $3 1M investment from Cantheon Capital
proactiveinvestors.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.ca Daily Mail and Mail on Sunday newspapers.

Jeff margolisArnold lippaResolutionrx ltdAustralian researchAustralian securities exchangeDevelopment tax incentiveRespirerx pharmaceuticalsCantheon capitalAustralian seriesPreference sharesRadium capital

RespireRx collaborating with University College London to study treatment options for GRIA disorders

RespireRx Pharmaceuticals (OTC:RSPI) Chief Scientific Officer Arnold Lippa joins Natalie Stoberman from the Proactive studios to share details of the.

Respirerx ampakinesArnold lippaNatalie stobermanRespirerx pharmaceuticalsUniversity college londonChief scientific officer arnold lippa

RespireRx collaborating with University College London to study treatment options for GRIA disorders

RespireRx Pharmaceuticals (OTC:RSPI) Chief Scientific Officer Arnold Lippa joins Natalie Stoberman from the Proactive studios to share details of the.

Natalie stobermanRespirerx ampakinesArnold lippaUniversity college londonRespirerx pharmaceuticalsChief scientific officer arnold lippa

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.